78 / 84
78
in patients with ankylosing spondylitis. Ann Rheum
Dis 2008;67:346-52.
46. Calin A, Dijkmans BA, Emery P, Hakala M,
Kalden J, Leirisalo-Repo M, et al. Outcomes of a
multicentre randomised clinical trial of etanercept to
treat ankylosing spondylitis. Ann Rheum Dis
2004;63:1594-600.
47. Dougados M, Braun J, Szanto S, Combe B, Elbaz
M, Geher P, et al. Efficacy of etanercept on
rheumatic signs and pulmonary function tests in
advanced ankylosing spondylitis: results of a
randomised double-blind placebo-controlled study
(SPINE). Ann Rheum Dis 2011;70:799-804.
48. Navarro-Sarabia F, Fernández-Sueiro JL, Torre-
Alonso JC, Gratacos J, Queiro R, Gonzalez C, Loza
E, et al. High-dose etanercept in ankylosing
spondylitis: results of a 12-week randomized,
double blind, controlled multicentre study
(LOADET
study).
Rheumatology
(Oxford)
2011;50:1828-37.
49. Revicki DA, Luo MP, Wordsworth P, Wong RL,
Chen N, Davis JC Jr, et al. Adalimumab reduces
pain, fatigue, and stiffness in patients with
ankylosing
spondylitis:
results
from
the
adalimumab trial evaluating long-term safety and
efficacy for ankylosing spondylitis (ATLAS). J
Rheumatol 2008;35:1346-53.